ID   HERLUF
AC   CVCL_E693
SY   HERLUF2; HERLUFF; Herluff; GM03160; GM3160
DR   CLO; CLO_0013515
DR   Coriell; GM03160
DR   dbMHC; 48889
DR   ECACC; 87031104
DR   IHW; IHW09299
DR   IPD-IMGT/HLA; 10728
DR   Wikidata; Q54882891
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Danish.
CC   HLA typing: A*02:01:01:01; B*44:02:01:01,35:03:01:01; C*05:01:01:02,04:01:01:01; DPA1*01,02; DPB1*04:01:01; DQA1*05:01; DQB1*03:01:01; DRB1*12:01:01/12:10; DRB3*02:02 (IPD-IMGT/HLA=10728).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=6200433; DOI=10.1007/BF00364762;
RA   Brodsky F.M.;
RT   "A matrix approach to human class II histocompatibility antigens:
RT   reactions of four monoclonal antibodies with the products of nine
RT   haplotypes.";
RL   Immunogenetics 19:179-194(1984).
//
RX   PubMed=29171935; DOI=10.1111/tan.13184;
RA   Turner T.R., Hayhurst J.D., Hayward D.R., Bultitude W.P., Barker D.J.,
RA   Robinson J., Madrigal J.A., Mayor N.P., Marsh S.G.E.;
RT   "Single molecule real-time DNA sequencing of HLA genes at ultra-high
RT   resolution from 126 international HLA and immunogenetics workshop cell
RT   lines.";
RL   HLA 91:88-101(2018).
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//